Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Consolidated Net IncomeCost of RevenueEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Gross ProfitIncome from Continuing OperationsIncome towards Parent CompanyInterest ExpensesNet Income towards Common StockholdersNon Operating IncomeNon Operating Investment IncomeOperating ExpensesOperating IncomeOther Non Operating IncomeOther Operating ExpensesProfit After TaxResearch & DevelopmentRevenueSelling, General & AdministrativeTax ProvisionsTax Rate
Others
Ratios

Cryo Cell International (CCEL) EBIT: 2010-2024

Historic EBIT for Cryo Cell International (CCEL) over the last 15 years, with FY2024 value amounting to $3.5 million.

  • Cryo Cell International's EBIT rose 3674.0% to $1.9 million in Q3 2025 from the same period last year, while for Aug 2025 it was $4.3 million, marking a year-over-year increase of 13441.23%. This contributed to the annual value of $3.5 million for FY2024, which is 12828.57% up from last year.
  • Cryo Cell International's EBIT amounted to $3.5 million in FY2024, which was up 12828.57% from -$12.3 million recorded in FY2023.
  • In the past 5 years, Cryo Cell International's EBIT registered a high of $7.7 million during FY2020, and its lowest value of -$12.3 million during FY2023.
  • Over the past 5 years, Cryo Cell International's median EBIT value was $4.0 million (recorded in 2021), while the average stood at $1.4 million.
  • Per our database at Business Quant, Cryo Cell International's EBIT crashed by 40573.07% in 2023 and then skyrocketed by 12828.57% in 2024.
  • Annual analysis of 5 years shows Cryo Cell International's EBIT stood at $7.7 million in 2020, then plummeted by 47.55% to $4.0 million in 2021, then grew by 0.16% to $4.0 million in 2022, then crashed by 405.73% to -$12.3 million in 2023, then surged by 128.29% to $3.5 million in 2024.
  • Its last three reported values are $3.5 million in FY2024, -$12.3 million for FY2023, and $4.0 million during FY2022.